logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Admission applications = more appeals

7 January 2013

The Telegraph reports that the 20 most popular schools are receiving 8 or more applications per school place. Whilst evidencing the well publicised strain on good schools, there is no mention of the inevitable impact on admission appeals. 

For the 2010 entry, 83,470 appeals were lodged against non-admission, 60,010 of which resulted in an appeal hearing before an independent panel.

All that is required to trigger a right of appeal is the refusal of a place. There is no test, no need to prove inequity and no requirement to allege procedural unfairness. With no hurdles to overcome, I expect the majority of these parents to exercise their right of appeal against all schools which refused their application. 

This is likely to result in at least 100,000 appeals for 2013 entry, with a cost of facilitating these appeals running into the tens of millions. Could those funds not be better spent elsewhere within education?

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up